Sonendo, Inc. (SONX)

Market Cap	6.25M
Revenue (ttm)	43.87M
Net Income (ttm)	-61.48M
Shares Out	66.78M
EPS (ttm)	-0.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	145,631
Open	0.0894
Previous Close	0.0906
Day's Range	0.0876 - 0.0960
52-Week Range	0.0450 - 1.8000
Beta	1.66
Analysts	Buy
Price Target	1.69 (+1,705.56%)
Earnings Date	Nov 8, 2023

About SONX

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 29, 2021
• Employees: 200
• Stock Exchange: OTCMKTS
• Ticker Symbol: SONX

Financial Performance

In 2023, Sonendo's revenue was $43.87 million, an increase of 5.30% compared to the previous year's $41.66 million. Losses were -$60.92 million, 6.78% more than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for SONX stock is "Buy." The 12-month stock price forecast is $1.69, which is an increase of 1,705.56% from the latest price.

Price Target

$1.69

(1,705.56% upside)

Analyst Consensus: Buy